Activation of β-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation

Oncogene

Volumn 22, Issue 25, 2003, Pages 3875-3887

  Bierie, Brian ^a   Nozawa, Masahiro ^a   Renou, Jean Pierre ^a,b   Shillingford, Jonathan M ^a   Morgan, Fanta ^a   Oka, Takami ^a   Taketo, Makoto M ^c   Cardiff, Robert D ^d   Miyoshi, Keiko ^a,e   Wagner, Kay Uwe ^f   Robinson, Gertraud W ^a   Hennighausen, Lothar ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b CEMAGREF   (France)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TOKUSHIMA   (Japan)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

catenin; Cell identity; Neoplasia; Prostate; Transdifferentiation

Indexed keywords

BETA CATENIN; FILAGGRIN; INVOLUCRIN; KERATIN; KERATIN 6; KERATIN TYPE 1; LORICRIN; PROTEIN; PROTEIN NKCC1; STAT5 PROTEIN; STAT5A PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SPECIFICITY; CELL TYPE; DEVELOPMENT; ENDODERM; EPIDERMIS CELL; EPIDIDYMIS; EXON; GENE DELETION; INTESTINE EPITHELIUM; LONG TERMINAL REPEAT; MALE; MALIGNANT TRANSFORMATION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PREPUTIAL GLAND; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; SALIVARY GLAND; SIGNAL TRANSDUCTION; SQUAMOUS CELL METAPLASIA; TRANSGENE; VAS DEFERENS;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, DIFFERENTIATION; BETA CATENIN; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; ENDODERM; EPITHELIAL CELLS; EXONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HYPERPLASIA; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; METAPLASIA; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROSTATE; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; TERMINAL REPEAT SEQUENCES; TRANS-ACTIVATORS; TRANSGENES; TRANSPLANTATION, HETEROTOPIC;

ANIMALIA; MAMMALIA; MOUSE MAMMARY TUMOR VIRUS; ONCOVIRINAE;

EID: 0038339044     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206426     Document Type: Article

References (53)

1. Achtstatter T, Moll R, Moore B and Franke WW. (1985). J. Histochem. Cytochem., 33, 415-426.
2. Alberts AS and Treisman R. (1998). EMBO J., 17, 4075-4085.
3. Barresi G and Tuccari G. (1984). Virchows Arch. A., 403, 59-66.
4. Baruch RR, Melinscak H, Lo J, Liu Y, Yeung O and Hurta RA. (2001). Cell Biol. Int., 25, 411-420.
5. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, Sommer L, Boussadia O and Kemler R. (2001). Development, 128, 1253-1264.
6. Chesire DR, Ewing CM, Gage WR and Isaacs WB. (2002). Oncogene, 21, 2679-2694.
7. Chesire DR, Ewing CM, Sauvageot J, Bova GS and Isaacs WB. (2000). Prostate, 45, 323-334.
8. de Lau W and Clevers H. (2001). Nat. Genet., 28, 3-4.
9. DeOme KB, Faulkin Jr LJ, Bern HA and Blair PE. (1959). Cancer Res., 19, 515-520.
10. Fischer DF, van Drunen CM, Winkler GS, van de Putte P and Backendorf C. (1998). Nucleic Acids Res., 26, 5288-5294.
11. Fuchs E and Byrne C. (1994). Curr. Opin. Genet. Dev., 4, 725-736.
12. Gat U, DasGupta R, Degenstein L and Fuchs E. (1998). Cell, 95, 605-614.
13. Gerstein AV, Almeida TA, Zhao G, Chess E, Shih Ie M, Buhler K, Pienta K, Rubin MA, Vessella R and Papadopoulos N. (2002). Genes Chromosomes Cancer, 34, 9-16.
14. Gounari F, Signoretti S, Bronson R, Klein L, Sellers WR, Kum J, Siermann A, Taketo MM, von Boehmer H and Khazaie K. (2002). Oncogene, 21, 4099-4107.
15. Haegel H, Larue L, Ohsugi M, Fedorov L, Herrenknecht K and Kemler R. (1995). Development, 121, 3529-3537.
16. Harada N, Miyoshi H, Murai N, Oshima H, Tamai Y, Oshima M and Taketo MM. (2002). Cancer Res., 62, 1971-1977.
17. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M and Taketo MM. (1999). EMBO J., 18, 5931-5942.
18. Hovanes K, Li TW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF and Waterman ML. (2001). Nat. Genet., 28, 53-57.
19. Huelsken J and Birchmeier W. (2001). Curr. Opin. Genet. Dev., 11, 547-553.
20. Huelsken J, Vogel R, Brinkmann V, Erdmann B, Birchmeier C and Birchmeier W. (2000). J. Cell Biol., 148, 567-578.
21. Huelsken J, Vogel R, Erdmann B, Cotsarelis G and Birchmeier W. (2001). Cell, 105, 533-545.
22. Humphreys RC and Hennighausen L. (1999). Cell Growth Differ., 10, 685-694.
23. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N and Ross JS. (2001). Clin. Cancer Res., 7, 3113-3119.
24. Kondo M, Scherer DC, Miyamoto T, King AG, Akashi K, Sugamura K and Weissman IL (2000). Nature, 407, 383-386.
25. Krempler A, Henry MD, Triplet AA and Wagner KU. (2002). J. Biol. Chem., 277, 43216-43223.
26. Li XF, Thinakaran G, Sisodia SS and Yu FS. (1999). J. Biol. Chem., 274, 27249-27256.
27. Liu X, Robinson GW and Hennighausen L. (1996). Mol. Endocrinol., 10, 1496-1506.
28. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A and Hennighausen L. (1997). Genes Dev., 11, 179-186.
29. McCrea PD, Turck CW and Gumbiner B. (1991). Science, 254, 1359-1361.
30. Merrill BJ, Gat U, DasGupta R and Fuchs E. (2001). Genes Dev., 15, 1688-1705.
31. Miyoshi K, Shillingford JM, Smith GH, Grimm SL, Wagner KU, Oka T, Rosen JM, Robinson GW and Hennighausen, L. (2001). J. Cell Biol., 155, 531-542.
32. Miyoshi K, Meyer B, Gruss P, Cui Y, Renou JP, Morgan FV, Smith GH, Reichenstein M, Shani, M and Hennighausen, L and Robinson, GW. (2002b). Mol. Endocrinol., 16, 2892-2901.
33. Miyoshi K, Rosner A, Nozawa M, Byrd C, Morgan F, Landesman-Bollag E, Xu X, Seldin DC, Schmidt EV, Taketo MM, Robinson GW, Cardiff RD and Hennighausen L. (2000c). Oncogene, 21, 5548-5556.
34. Miyoshi K, Shillingford JM, Le Provost F, Gounari F, Bronson R, von Boehmer H, Taketo MM, Cardiff RD, Hennighausen L and Khazaie K. (2002a). Proc. Natl. Acad. Sci. USA, 99, 219-224.
35. Nevalainen MT, Ahonen TJ, Yamashita H, Chandrashekar V, Bartke A, Grimley PM, Robinson GW, Hennighausen L and Rui H. (2000). Lab. Invest., 80, 993-1006.
36. Niemann C, Owens DM, Hulsken J, Birchmeier W and Watt PM. (2002). Development, 129, 95-109.
37. Oettgen P, Kas K, Dube A, Gu X, Grall F, Thamrongsak U, Akbarali Y, Finger E, Boltax J, Endress G, Munger K, Kunsch C and Libermann TA. (1999). J. Biol. Client., 274, 29439-29452.
38. Polakis P. (2000). Genes Dev., 14, 1837-1851.
39. Reese JH, McNeal JE, Goldenberg SL, Redwine EA and Sellers RG. (1992). Prostate, 20, 73-85.
40. Robinson GW, McKnight RA, Smith GH, Hennighausen L. (1995). Development, 121, 2079-2090.
41. Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J and Iruela-Arispe ML. (2001). Proc. Natl. Acad. Sci. USA, 98, 12485-12490.
42. Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, Logtenberg T and Clevers H. (1999). Science, 285, 1923-1926.
43. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL and MacDougald OA (2000). Science, 289, 950-953.
44. Shen X, Li J, Hu PP, Waddell D, Zhang J and Wang XF. (2001). J. Biol. Chem., 276, 15362-15368.
45. Shillingford JM, Miyoshi K, Flagella M, Shull GE and Hennighausen L. (2002a). Mol. Endocrinol., 16, 1309-1321.
46. Shillingford JM, Miyoshi K, Robinson GW, Grimm SL, Rosen JM, Neubauer H, Pfeffer K and Hennighausen L. (2002b). Mol. Endocrinol., 16, 563-570.
47. Slunt HH, Thinakaran G, Von Koch C, Lo AC, Tanzi RE and Sisodia, SS. (1994). J. Biol. Chem., 269, 2637-2644.
48. Song HJ, Poy G, Darwiche N, Lichti U, Kuroki T, Steinert PM and Kartasova T (1999). Genomics, 55, 28-42.
49. Voeller HJ, Truica CI and Gelmann EP. (1998). Cancer Res., 58, 2520-2523.
50. Wagner KU, McAllister K, Ward T, Davis B, Wiseman R and Hennighausen L (2001). Transgenic Res., 10, 545-553.
51. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA and Hennighausen L. (1997). Nucleic Acids Res., 25, 4323-4330.
52. Watt FM and Hogan BL. (2000). Science, 287, 1427-1430.
53. Widelitz RB, Jiang TX, Lu J and Chuong CM. (2000). Dev. Biol., 219, 98-114.